[8] Fizazi K, Tran N, Fein L, et al. Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, ...
[8] Fizazi K, Tran N, Fein L, et al. Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial.[J].Lancet Oncol.2019 May;20(5):686-...
[4] de la Calle C,et al. Multicenter Evaluation of the Prostate Health Index (PHI) for Detectionof Aggressive Prostate Cancer in Biopsy-Naive Men. J Urol(2015), doi:10.1016/j.juro.2015.01.091. [5] Russo GI,...
[8] Fizazi K, Tran N, Fein L, et al. Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial.[J].Lancet Oncol.2019 May;20(5):686-...
[5] Russo GI, et al. A SystematicReview and Meta-analysis of the Diagnostic Accuracy of Prostate Health Indexand 4-Kallikrein Panel Score in Predicting Overall and High-grade ProstateCancer.Clinical Genitourinary Cancer(2016). doi: 10.1016/j.clgc.2016.12.022 ...
[5] Russo GI, et al. A SystematicReview and Meta-analysis of the Diagnostic Accuracy of Prostate Health Indexand 4-Kallikrein Panel Score in Predicting Overall and High-grade ProstateCancer.Clinical Genitourinary Cancer(2016). doi: 10.1016/j.clgc.2016.12.022 ...
[1].Chi K M, et al. Final analysis results from TITAN: a phase 3 study of apalutamide vs placebo in patients with metastatic castration-sensitive prostate cancer receiving androgen deprivation therapy. J Clin Oncol 39, 2021 (suppl 6; abstr 11). ...
[6].Fizazi K, et al. Lancet Oncol. Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial. 2019; 20(5):686-700. ...
PSA testingis used to identify theearly stagesof prostate cancer. It is currently one of the few widely used tests for prostate cancer available. The other examination used to detect this cancer is a digital rectal examination (DRE), in which a doctor inserts a gloved finger into therectum(...
[2] Fizazi K, et al. Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial. Lancet Oncol. 2019 May;20(5):686-700....